Role of eicosanoids in the control of renal function in severe hepatic disease.
D000818:Animals; D001095:Arachidonic Acids / Q000378:metabolism*; D001241:Aspirin / Q000494:pharmacology; D004285:Dogs; D006801:Humans; D007052:Ibuprofen / Q000494:pharmacology; D007213:Indomethacin / Q000494:pharmacology; D007668:Kidney / Q000098:blood supply / Q000187:drug effects / Q000378:metabolism*; D008084:Lipoxygenase / Q000378:metabolism; D008103:Liver Cirrhosis / Q000378:metabolism*; D010740:Phospholipases / Q000378:metabolism; D011451:Prostaglandin-Endoperoxide Synthases / Q000378:metabolism; D011453:Prostaglandins / Q000378:metabolism; D012039:Regional Blood Flow / Q000187:drug effects; D013931:Thromboxanes / Q000378:metabolism; D014661:Vasoconstriction / Q000187:drug effects
D001095:Arachidonic Acids; D011453:Prostaglandins; D013931:Thromboxanes; D008084:Lipoxygenase; D011451:Prostaglandin-Endoperoxide Synthases; D010740:Phospholipases; D001241:Aspirin; D007052:Ibuprofen; D007213:Indomethacin